Cognitive Stimulation Therapy - Effects on Cognitive and Functional Domains in Dementia - A Retrospective Data Review (CST)

May 30, 2025 updated by: Frank Lai, Northumbria University

Cognitive Stimulation Therapy vs. Reality Orientation & Reminiscence Therapy: Effects on Cognitive and Functional Domains in Dementia - Retrospective Study

This retrospective, single-blind, parallel group study investigates the efficacy of Cognitive Stimulation Therapy (CST) compared to Reality Orientation and Reminiscence Therapy (RO&RM) in enhancing cognitive and functional domains in older adults with mild to moderate dementia.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Through data review, this retrospective, single-blind, parallel group study investigates the efficacy of Cognitive Stimulation Therapy (CST) compared to Reality Orientation and Reminiscence Therapy (RO&RM) in enhancing cognitive and functional domains in older adults with mild to moderate dementia.

Study Type

Observational

Enrollment (Actual)

160

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Older people who are residence in a 24/7 care home

Description

Inclusion Criteria:

  • participants had to be 65 years old or above, live in Hong Kong and had a diagnosis for dementia in medical history

Exclusion Criteria:

  • any major neurological illness other than dementia, any psychiatric disorder or a known history of substance abuse.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cognitive Stimulation Therapy
Therapy in the CST arm focused on improving participants' attention span, memory and problem-solving skills using paper and pen, table games or computer programs.
Behavioral: Cognitive Remediation
cognitive remediation
RO&RM arm
with the use of orientation boards, calendars, clocks, verbal reminders, and different environmental cues to reduce participants' confusion, disorientation and behavioral problems.
Behavioral: Cognitive Remediation
cognitive remediation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kendrick Cognitive Test for the Elderly (KCTE).
Time Frame: Baseline line and six-month
Participants' attention and episodic memory were quantified using the Kendrick Cognitive Test for the Elderly (KCTE).
Baseline line and six-month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Chinese Disability Assessment for Dementia (CDAD)
Time Frame: Baseline and 6-month after the start of the program
for assessing executive function in older adults with dementia. Its focus on initiating, planning, and executing activities provides a practical and ecologically valid measure of executive dysfunction, aligning closely with the real-world challenges faced by older Chinese people with dementia.
Baseline and 6-month after the start of the program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Northumbria University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Actual)

April 2, 2025

Study Completion (Actual)

April 2, 2025

Study Registration Dates

First Submitted

April 10, 2025

First Submitted That Met QC Criteria

April 10, 2025

First Posted (Actual)

April 17, 2025

Study Record Updates

Last Update Posted (Actual)

May 31, 2025

Last Update Submitted That Met QC Criteria

May 30, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CST - Retrospective Datareview

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on Cognitive Remediation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe